Search results
Dec 13, 2020 · CEO John Graham says the No. 1 distributor of vaccines in Asia is up for the challenge to deliver Covid-19 vaccines at sub-zero temperatures
John R. Graham (born June 1, 1961) is an American financial economist, a professor at the Duke University Fuqua School of Business, a research associate for the NBER, and a regular guest commentator on CNBC.
John Graham leads the Zuellig Pharma Executive Management team. His vision is to transform Zuellig Pharma into an indispensable strategic partner to those engaged in the Asian healthcare ecosystem, by providing a full spectrum of innovative and integrated solutions across the healthcare value chain. <br /> <br /> John brings with him over 30 ...
View John A. Graham’s profile on LinkedIn, a professional community of 1 billion members. John is a senior healthcare executive and leader, with more than 30 years of global… · Experience:...
- Zuellig Pharma
John R. Graham is D. Richard Mead professor of finance at the Fuqua School of Business, where he has won the Outstanding Faculty and several Best Teacher awards, and a research associate of the National Bureau of Economic Research.
John R. Graham. D. Richard Mead Jr. Family Professor of Finance, Duke University. Research Associate, NBER. Academic Fellow, UNC Tax Center. Director: The CFO Survey (Duke, Federal Reserve Banks of Atlanta and Richmond) Google Scholar Link. SSRN link to working paper versions of research.
John Graham was a Russian-born painter whose work as an organizer and writer helped bring widespread recognition to the New York School. His style was influenced by his acquaintances among the European avant-garde.
John Edward Graham is an Australian politician. He has been a Labor member of the New South Wales Legislative Council since October 2016 and has been Special Minister of State and Minister for Roads, the Arts, Music, the Night-time Economy, Jobs and Tourism since 2023.
Articles 1–20. Professor of Finance, Fuqua School of Business, Duke University - Cited by 63,882 - Finance.
Jul 1, 2020 · Zuellig Pharma announces the appointment of John Graham as its new CEO. John will run the US$13 billion business and lead the team across our 13 markets in Asia.
